Emili Montserrat | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Emili Montserrat is active.

Explore More

Publication

Featured researches published by Emili Montserrat.

Archive | 2014

lymphocytic leukemia fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic Rituximab maintenance after first-line therapy with rituximab,

Xavier Calvo; Sabela Bobillo; José Bruno Montoro; Emili Montserrat; Francesc Bosch; Secundino Ferrer; Encarna Monzo; Isidro Jarque; Eugenia Abella; Julio Delgado; José A. García-Marco; Yolanda Gonzalez; Felix Carbonell; Pau Abrisqueta; Neus Villamor; Maria Jose Terol; Eva González-Barca; Marcos González

Archive | 2013

immunophenotyping in patients with diffuse large B-cell lymphoma Clinical impact of the differentiation profile assessed by

Francesc Bosch; Dolors Colomer; Emili Montserrat; Armando López-Guillermo; Susana Rives; Antonio Marti

Archive | 2013

number of donor CD34+ cells? identical siblings: detrimental effect of a high - human leukocyte antigen Allogeneic transplantation of CD34+selected cells from peripheral blood from

Blanca Xicoy; Juan-Carlos Hernández-Boluda; Emili Montserrat; Alvaro Urbano-Ispizua; Enric Carreras; Pedro Mari; Montserrat Rovira; Carmen Marti

Archive | 2013

Survival Prediction that Influence Tumor Biology and Improve Gene Expression-Based Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles

Andreas Rosenwald; Greiner C Timothy; Holte Harald; Powell John; Emili Montserrat; Hans-Konrad Müller-Hermelink; Louis M. Staudt; Elias Campo; Erlend B. Smeland; Stein Kvaloy; Jan Delabie; Richard Simon; Randy D. Gascoyne; Joseph M. Connors; Xavier Puig; Liming Yang; Armando López-Guillermo; Wing C. Chan; Andreas Zettl; George W. Wright; Itziar Salaverria; Philipp Jehn; Victor Moreno; Christof Burek

Archive | 2013

mechanism involving the generation of reactive oxygen species lymphoproliferative disorders is mediated in vitro by a caspase-independent Complement-mediated cell death induced by rituximab in B-cell

Emili Montserrat; Beatriz Bellosillo; Neus Villamor; Armando López-Guillermo; Silvia Marcé; Elias Campo

Archive | 2011

allogeneic stem cell transplantation for chronic lymphocytic leukemia Different clinical value of minimal residual disease after autologous and

Jordi Esteve; Neus Villamor; Dolors Colomer; Emili Montserrat

Archive | 2011

associated with improved overall survival in follicular lymphoma High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are

Giovanna Roncador; Emili Montserrat; Elias Campo; Alison H. Banham; Joaquim Carreras; Armando López-Guillermo; Bridget C. Fox; Lluis Colomo; Antonio Martínez

Archive | 2011

and activates p53-independent mitochondrial apoptosis by induction of Forodesine has high antitumor activity in chronic lymphocytic leukemia

Dolors Colomer; Thomas Mehrling; Neus Villamor; Elias Campo; Emili Montserrat; Roberto Alonso; Mónica López-Guerra; Ramanda Upshaw; Shanta Bantia; Caroline Smal

Archive | 2008

Short Title: Inflammasome genetic variants in allo-SCT

Miquel Granell; Alvaro Urbano-Ispizua; Aina Pons; Juan I. Aróstegui; Bernat Gel; Alfons Navarro; Sonia Jansa; Rosa Artells; Anna Gaya; Carme Talarn; Francesc Fernández-Avilés; Carmen Martínez; Montserrat Rovira; Enric Carreras; Ciril Rozman; Manel Juan; Jordi Yagüe; Emili Montserrat; Mariano Monzo

Blood | 2007

Molecular Markers Predicting Clinical Outcome in Patients with Intermediate-Risk Acute Myeloid Leukemia Receiving Autologous Stem Cell Transplantation.

Jordi Esteve; Susana G. Kalko; Montserrat Torrebadell; Mireia Camós; Pedro Jares; Maria Rozman; Marta Pratcorona; Salut Brunet; Josep Nomdedeu; Ana Carrio; Dolors Costa; Emili Montserrat

Explore More